Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Status:
Completed
Trial end date:
2019-09-04
Target enrollment:
Participant gender:
Summary
This study uses a special type of scan called a positron emission tomography (PET) scan to
take pictures of the brain. During the PET scan, a special dye called 11C-PBR28 is injected
into the body.
11C-PBR28 sticks to parts of the brain where there is inflammation. The purpose of this study
is to see if 11C-PBR28 can detect inflammation in patients with Parkinson's disease dementia
or dementia with Lewy bodies.
11C-PBR28 is considered a drug by the Food and Drug Administration. 11C-PBR28 is not a
treatment for any disease. Rather, 11C-PBR28 can be used to measure inflammation in the
brain.